Multiple Sclerosis, Infertility and its Treatment
Authors:
I. Šrotová 1,2; I. Crha 3; E. Vlčková 1,2; M. Svobodová 1,2; E. Nekvapilová 2; P. Štourač 1,2; J. Bednařík 1,2
Authors‘ workplace:
Neurologická klinika LF MU a FN Brno
1; CEITEC – Středoevropský technologický institut, MU, Brno
2; Gynekologicko-porodnická klinika LF MU a FN Brno
3
Published in:
Cesk Slov Neurol N 2015; 78/111(6): 655-660
Category:
Review Article
Overview
Multiple sclerosis is a common autoimmune disease affecting young people, with onset usually at the age of 20– 40 years. During these decades patients are usually planning pregnancy. In patients with multiple sclerosis fertility seems to be slightly impaired. Several factors might contribute to this condition. It is mainly sexual dysfunctions, which belong to comparatively common symptoms of the disease, hormonal alteration, concomitant (autoimmune) disease and specific therapy of multiple sclerosis. Psychosocial factors have an influence on fertility and its therapy. The aim of this review is description of factors potentially interfering with fertility in multiple, the current applications of assisted reproductive techniques and its influence on course of multiple sclerosis.
Key words:
multiple sclerosis – infertility – in vitro fertilisation – endometriosis – sexual dysfunctions – sexual hormons
The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.
The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.
Sources
1. Vachová M. Epidemie roztroušené sklerózy ve světě? Cesk Slov Neurol N 2012; 75/ 108(6): 701– 706.
2. Duquette P, Pleines J, Girard M, Charest L, Senecal‑ Quevillon M, Masse C. The increased susceptibility of women to multiple sclerosis. Can J Neurol Sci 1992; 19(4): 466– 471.
3. Compston A, Coles A. Multiple sclerosis. Lancet 2002; 359(9313): 1221– 1231.
4. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69(2): 292– 302. doi: 10.1002/ ana.22366.
5. Alwan S, Chambers CD, Armenti VT, Sadovnick AD. The need for a disease‑ specific prospective pregnancy registry for multiple sclerosis (MS). Mult Scler Relat Disord 2015; 4(1): 6– 17. doi: 10.1016/ j.msard.2014.10.001.
6. Meluzínová E. Těhotenství a roztroušená skleróza. Neurol Prax 2010; 11(5): 293– 295.
7. Confavreux C, Hutchinson M, Hours M, Cortinovis‑ Tourniaire P, Moreau T. Rate of pregnancy‑related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998; 339(5): 285– 291.
8. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995; 118(1): 253– 261.
9. Crha I. Farmakoterapie v reprodukční medicíně. Prakt Lekaren 2010; 6(4): 173– 176.
10. Řežábek K. Asistovaná reprodukce. Praha: Maxdorf 2008.
11. Mosher WD, Pratt WF. Fecundity and infertility in the United States: incidence and trends. Fertil Steril 1991; 56(2): 192– 193.
12. Cavalla P, Rovei V, Masera S, Vercellino M, Massobrio M, Mutani R et al. Fertility in patients with multiple sclerosis: current knowledge and future perspectives. Neurol Sci 2006; 27(4): 231– 239.
13. Jalkanen A, Alanen A, Airas L. Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland. Mult Scler 2010; 16(8): 950– 955. doi: 10.1177/ 1352458510372629.
14. Grinsted L, Heltberg A, Hagen C, Djursing H. Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis. J Intern Med 1989; 226(4): 241– 244.
15. Lombardi G, Celso M, Bartelli M, Cilotti A, Del Popolo G. Female sexual dysfunction and hormonal status in multiple sclerosis patients. J Sex Med 2011; 8(4): 1138– 1146. doi: 10.1111/ j.1743‑ 6109.2010.02161.x.
16. Sloka JS, Phillips PW, Stefanelli M, Joyce C. Co‑ occurrence of autoimmune thyroid disease in a multiple sclerosis cohort. J Autoimmune Dis 2005; 2: 9.
17. Demirkiran M, Sarica Y, Uguz S, Yerdelen D, Aslan K. Multiple sclerosis patients with and without sexual dysfunction: are there any differences? Mult Scler 2006; 12(2): 209– 214.
18. Gnoth C, Godehardt E, Frank‑ Herrmann P, Friol K, Tigges J, Freundl G. Definition and prevalence of subfertility and infertility. Hum Reprod 2005; 20(5): 1144– 1147.
19. Zorzon M, Zivadinov R, Bosco A, Bragadin LM, Moretti R, Bonfigli L et al. Sexual dysfunction in multiple sclerosis: a case‑ control study. I. Frequency and comparison of groups. Mult Scler 1999; 5(6): 418– 427.
20. Foley FW, Zemon V, Campagnolo D, Marrie RA, Cutter G, Tyry T et al. The Multiple Sclerosis Intimacy and Sexuality Questionnaire – re‑validation and development of a 15- item version with a large US sample. Mult Scler 2013; 19(9): 1197– 1203. doi: 10.1177/ 1352458512471876.
21. Borello‑ France D, Leng W, O‘Leary M, Xavier M, Erickson J, Chancellor MB et al. Bladder and sexual function among women with multiple sclerosis. Mult Scler 2004; 10(4): 455– 461.
22. Barnhart K, Osheroff J. Follicle stimulating hormone as a predictor of fertility. Curr Opin Obstet Gynecol 1998; 10(3): 227– 232.
23. Sills ES, Alper MM, Walsh AP. Ovarian reserve screening in infertility: practical applications and theoretical directions for research. Eur J Obstet Gynecol Reprod Biol 2009; 146(1): 30– 36. doi: 10.1016/ j.ejogrb.2009.05.008.
24. Cil AP, Leventoğlu A, Sönmezer M, Soylukoç R, Oktay K. Assessment of ovarian reserve and Doppler characteristics in patients with multiple sclerosis using immunomodulating drugs. J Turk Ger Gynecol Assoc 2009; 10(4): 213– 219.
25. Thöne J, Kollar S, Nousome D, Ellrichmann G, Kleiter I, Gold R et al. Serum anti‑Müllerian hormone levels in reproductive‑ age women with relapsing‑ remitting multiple sclerosis. Mult Scler 2015; 21(1): 41– 47. doi: 10.1177/ 1352458514540843.
26. Kučera R, Topolčan O, Rumpíková T, Rumpík D, Dostál J. Stanovení anti‑Müllerova hormonu u žen. Čes Gynek 2013; 78(3): 282– 288.
27. Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 2002; 52(4): 421– 428.
28. Soldan SS, Alvarez Retuerto AI, Sicotte NL, Voskuhl RR. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J Immunol 2003; 171(11): 6267– 6274.
29. Falaschi P, Martocchia A, Proietti A, D‘Urso R, Antonini G. High incidence of hyperandrogenism‑related clinical signs in patients with multiple sclerosis. Neuro Endocrinol Lett 2001; 22(4): 248– 250.
30. Safarinejad MR. Evaluation of endocrine profile, hypothalamic‑ pituitary‑ testis axis and semen quality in multiple sclerosis. J Neuroendocrinol 2008; 20(12): 1368– 1375.
31. Goldstein DP, deCholnoky C, Emans SJ, Leventhal JM. Laparoscopy in the diagnosis and management of pelvic pain in adolescents. J Reprod Med 1980; 24(6): 251– 256.
32. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997; 24(2): 235– 258.
33. Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod 2002; 17(10): 2715– 2724.
34. Berkkanoglu M, Arici A. Immunology and endometriosis. Am J Reprod Immunol 2003; 50(1): 48– 59.
35. Karásek D, Oborná I, Fryšák Z. Autoimunitní tyreoiditida a neplodnost. Interní Med 2007; 9(9): 394– 397.
36. Havrdova E, Horakova D, Kovarova I. Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use. Ther Adv Neurol Disord 2015; 8(1): 31– 45.
37. Magyari M, Koch‑ Henriksen N, Pfleger CC, Sørensen PS. Gender and autoimmune comorbidity in multiple sclerosis. Mult Scler 2014; 20(9): 1244– 1251.
38. Lu E, Zhu F, Zhao Y, van der Kop M, Sadovnick A, Synnes A et al. Birth outcomes of pregnancies fathered by men with multiple sclerosis. Mult Scler 2014; 20(9): 1260– 1264.
39. Khademi A, Alleyassin A, Aghhosseini M, Ramezanzadeh F, Abhari AA. Pretreatment beck depression inventory score is an important predictor for post‑treatment score in infertile patients; a before‑after study. BMC Psychiatry 2005; 5(1): 25
40. El Kissi Y, Romdhane AB, Hidar S, Bannour S, Ayoubi Idrissi K, Khairi H et al. General psychopathology, anxiety, depression and self‑ esteem in couples undergoing infertility treatment: a comparative study between men and women. Eur J Obstet Gynecol Reprod Biol 2013; 167(2): 185– 189. doi: 10.1016/ j.ejogrb.2012.12.014.
41. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 2005; 76(4): 469– 475.
42. Feinstein A, O‘Connor P, Feinstein K. Multiple sclerosis, interferon beta‑1b and depression: a prospective investigation. J Neurol 2002; 249(7): 815– 820.
43. Masopust J, Vališ M, Taláb R. Psychické příznaky roztroušené mozkomíšní sklerózy. Čes Slov Psychiat 2007; 103(1): 47– 54.
44. Janssens AC, van Doorn PA, de Boer JB, van der Meché FG, Passchier J, Hintzen RQ. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol Scand 2003; 108(6): 389– 395.
45. Csemiczky G, Landgren BM, Collins A. The influence of stress and state anxiety on the outcome of IVF‑ treatment: psychological and endocrinological assessment of Swedish women entering IVF‑ treatment. Acta Obstet Gynecol Scand 2000; 79(2): 113– 118.
46. Smeenk JM, Verhaak CM, Eugster A, van Minnen A, Zielhuis GA, Braat DD. The effect of anxiety and depression on the outcome of in vitro fertilization. Hum Reprod 2001; 16(7): 1420– 1423.
47. Amato MP, Portaccio E. Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease‑ modifying drugs. CNS Drugs 2015; 29(3): 207– 220. doi: 10.1007/ s40263‑ 015‑ 0238‑ y.
48. Štourač P. Imunomodulační léčba roztroušené sklerózy mozkomíšní v klinických a zobrazovacích parametrech. Cesk Slov Neurol N 2012; 108(4): 404– 410.
49. Meistrich ML, Wilson G, Mathur K, Fuller LM, Rodriguez MA, McLaughlin P et al. Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin‘s disease. J Clin Oncol 1997; 15(12): 3488– 3495.
50. Cocco E, Sardu C, Gallo P, Capra R, Amato MP, Trojano M. Frequency and risk factors of mitoxantrone‑induced amenorrhea in multiple sclerosis: the FEMIMS study. Mult Scler 2008; 14(9): 1225– 1233.
51. Laplaud DA, Leray E, Barriere P, Wiertlewski S,Moreau T. Increase in multiple sclerosis relapse rate following in vitro fertilization. Neurology 2006; 66(8): 1280– 1281.
52. Michel L, Foucher Y, Vukusic S, Confavreux C, de Sèze J, Brassat D et al. Increased risk of multiple sclerosis relapse after in vitro fertilisation. J Neurol Neurosurg Psychiatry 2012; 83(8): 796– 802.
53. Hellwig K, Beste C, Brune N, Haghikia A, Müller T, Schimrigk S et al. Increased MS relapse rate during assisted reproduction technique. J Neurol 2008; 255(4): 592– 593. doi: 10.1007/ s00415‑ 008‑ 0607‑ 2.
54. Hellwig K, Schimrigk S, Beste C, Muller T, Gold R. Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. Eur Neurol 2009; 61(2): 65– 68. doi: 10.1159/ 000177937.
55. Correale J, Farez MF, Ysrraelit MC. Increase in multiple sclerosis activity after assisted reproduction technology. Ann Neurol 2012; 72(5): 682– 694. doi: 10.1002/ ana.23745.
56. Heesen C, Gold SM, Huitinga I, Reul JM. Stress and hypothalamic‑ pituitary‑adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis – a review. Psychoneuroendocrinology 2007; 32(6): 604– 618.
57. Vaknin‑Dembinsky A, Bdolah Y, Karussis D, Rosenthal G, Petrou P, Fellig Y et al. Tumefactive demyelination following in vitro fertilization (IVF). J Neurol Sci 2015; 348(2): 256– 258.
58. Okáčová I, Benešová Y, Štourač P, Pikulová H, Praksová P, Mitášová A et al. Neurologické komplikace spojené s asistovanou reprodukcí – kazuistika. Cesk Slov Neurol N 2012; 75/ 108(5): 637– 640.
59. Dafopoulos K, Griesinger G, Schultze‑ Mosgau A, Orief Y, Schöpper B, Nikolettos N et al. Cumulative pregnancy rate after ICSI with cryopreserved testicular tissue in non‑obstructive azoospermia. Reprod Biomed Online 2005; 10(4): 461– 466.
60. Huser M, Zakova J, Smardova L, Crha I, Janku P, Hudecek R et al. Combination of fertility preservation strategies in young women with recently diagnosed cancer. Eur J Gynaecol Oncol 2012; 33(1): 42– 50.
Labels
Paediatric neurology Neurosurgery NeurologyArticle was published in
Czech and Slovak Neurology and Neurosurgery
2015 Issue 6
Most read in this issue
- Orbital Tumors
- European Society of Cardiology Congress
- Familiar Amyloid Polyneuropathy – a Case Report
- Psychometric Properties of the Czech Version of Epworth Sleepiness Scale